Efficient assessment of drug efficacy and safety can be challenging without a predictive model. We develop and deliver iPSC-based drug discovery services to enhance cardiovascular and neural drug screening.

We combine our cardiovascular and neural cell knowledge with expertise in large-scale manufacturing to enable drug developers to bring predictive human disease biology earlier into the drug discovery process.